-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2024.
- AEON Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was -$2.3M, a 122% decline year-over-year.
- AEON Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $9.5M.
- AEON Biopharma, Inc. annual Nonoperating Income (Expense) for 2024 was -$31M.
- AEON Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.13M, a 141% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)